Sucralfate Suspension
Product Images NDC 55154-5790

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sucralfate (NDC 55154-5790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Sucralfate 1)

Structure (Sucralfate 1)
Chemical structure diagram of the active ingredient sucralfate. The drawing depicts a complex molecular arrangement with multiple oxygen and hydroxyl groups, including the formula components for aluminum hydroxide and water molecules specified as variables x and y, indicating polymeric structure elements.*
FDA Label Image

1g/10ml Bag Label (2271d920 944f 42ac 9de4 2c09447a55b3 00)

1g/10ml Bag Label (2271d920 944f 42ac 9de4 2c09447a55b3 00)
Label for Sucralfate Oral Suspension 1 g/10 mL, a prescription oral suspension. The label includes directions to shake well before use, storage instructions, and warnings. It notes the product is distributed by Cardinal Health 107, LLC and manufactured by PAI Pharma.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.